Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1989 1
2007 1
2009 1
2010 1
2011 2
2012 3
2014 1
2015 1
2017 2
2018 4
2019 7
2020 11
2021 7
2022 7
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

44 results
Results by year
Filters applied: . Clear all
Page 1
EGFR-mutated pulmonary choriocarcinoma combined with adenocarcinoma.
Shigematsu Y, Nakano K, Uchibori K, Inamura K. Shigematsu Y, et al. Among authors: uchibori k. J Thorac Oncol. 2022 Aug 10:S1556-0864(22)01501-5. doi: 10.1016/j.jtho.2022.07.1146. Online ahead of print. J Thorac Oncol. 2022. PMID: 35963570 No abstract available.
Soluble PD-L1 works as a decoy in lung cancer immunotherapy via alternative polyadenylation.
Sagawa R, Sakata S, Gong B, Seto Y, Takemoto A, Takagi S, Ninomiya H, Yanagitani N, Nakao M, Mun M, Uchibori K, Nishio M, Miyazaki Y, Shiraishi Y, Ogawa S, Kataoka K, Fujita N, Takeuchi K, Katayama R. Sagawa R, et al. Among authors: uchibori k. JCI Insight. 2022 Jan 11;7(1):e153323. doi: 10.1172/jci.insight.153323. JCI Insight. 2022. PMID: 34874919 Free PMC article.
Rapid genomic profiling of circulating tumor DNA in non-small cell lung cancer using Oncomine Precision Assay with Genexus™ integrated sequencer.
Low SK, Ariyasu R, Uchibori K, Hayashi R, Chan HT, Chin YM, Akita T, Harutani Y, Kiritani A, Tsugitomi R, Manabe R, Ogusu S, Amino Y, Kitazono S, Yanagitani N, Nakamura Y, Nishio M. Low SK, et al. Among authors: uchibori k. Transl Lung Cancer Res. 2022 May;11(5):711-721. doi: 10.21037/tlcr-21-981. Transl Lung Cancer Res. 2022. PMID: 35693289 Free PMC article.
A phase II feasibility study of carboplatin and nab-paclitaxel for advanced non-small cell lung cancer patients with interstitial lung disease (YLOG0114).
Sakashita H, Uchibori K, Jin Y, Tsutsui T, Honda T, Sakakibara R, Mitsumura T, Nukui Y, Shirai T, Masuo M, Suhara K, Furusawa H, Yamashita T, Ohba T, Saito K, Takagiwa J, Miyashita Y, Inase N, Miyazaki Y. Sakashita H, et al. Among authors: uchibori k. Thorac Cancer. 2022 May;13(9):1267-1275. doi: 10.1111/1759-7714.14376. Epub 2022 Mar 23. Thorac Cancer. 2022. PMID: 35322551 Free PMC article. Clinical Trial.
44 results